Suppr超能文献

环状RNA和微小RNA在乳腺癌耐药性及靶向治疗反应中的作用

The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer.

作者信息

Zhang Meilan, Zheng Zhaokuan, Wang Shouliang, Liu Ruihan, Zhang Mengli, Guo Zhiyun, Wang Hao, Tan Weige

机构信息

The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou 511400, Guangdong, China.

Department of Orthopedics, Affiliated Huadu Hospital, Southern Medical University (People's Hospital of HuaduDistrict), Guangzhou 510810, Guangdong, China.

出版信息

Cancer Drug Resist. 2024 Aug 20;7:30. doi: 10.20517/cdr.2024.62. eCollection 2024.

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs comprising 19-24 nucleotides that indirectly control gene expression. In contrast to other non-coding RNAs (ncRNAs), circular RNAs (circRNAs) are defined by their covalently closed loops, forming covalent bonds between the 3' and 5' ends. circRNAs regulate gene expression by interacting with miRNAs at transcriptional or post-transcriptional levels. Accordingly, circRNAs and miRNAs control many biological events related to cancer, including cell proliferation, metabolism, cell cycle, and apoptosis. Both circRNAs and miRNAs are involved in the pathogenesis of diseases, such as breast cancer. This review focuses on the latest discoveries on dysregulated circRNAs and miRNAs related to breast cancer, highlighting their potential as biomarkers for clinical diagnosis, prognosis, and chemotherapy response.

摘要

微小RNA(miRNA)是由19 - 24个核苷酸组成的小型非编码RNA,它们间接控制基因表达。与其他非编码RNA(ncRNA)不同,环状RNA(circRNA)由其共价闭合环定义,在3'和5'末端之间形成共价键。circRNA通过在转录或转录后水平与miRNA相互作用来调节基因表达。因此,circRNA和miRNA控制许多与癌症相关的生物学事件,包括细胞增殖、代谢、细胞周期和凋亡。circRNA和miRNA都参与疾病的发病机制,如乳腺癌。本综述重点关注与乳腺癌相关的失调circRNA和miRNA的最新发现,突出它们作为临床诊断、预后和化疗反应生物标志物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3777/11391347/c0f96416e4e6/cdr-7-30.fig.1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验